Trial | NCT03002545  Report issue

Title

Magnesium Supplementation in Type II Diabetes
Effects of a 12-week Supplementation With 400 mg Magnesium From Magnesium Citrate on Blood Sugar, Blood Pressure and Expression of Magnesium-sensitive Genes in Patients With Type II Diabetes

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    50
This study aims to determine how a 12-week magnesium supplementation with 400 mg magnesium from organic magnesium citrate affects blood glucose control and insulin resistance within patients with type 2 diabetes (HbA1c> 6%) and how the expression of certain Mg-sensitive transporting genes is affected .
The examinations are carried out in 50 subjects aged 20-80 years with existing type 2 diabetes (HbA1c> 6%). The target parameters are determined in the blood. Blood sampling takes place at confinement, after 6 weeks and at the end of the study (week 12). In addition, blood pressure is determined and general health condition of each subject is recorded by a standardized questionnaire (SF-36).
Study Started
Dec 31
2016
Primary Completion
Mar 31
2019
Study Completion
Jul 31
2019
Last Update
Aug 28
2019

Dietary Supplement Magnesium citrate

Dietary Supplement Placebo

Placebo Placebo Comparator

identically tasting and looking Placebo

Magnesium Active Comparator

Supplementation with 400 mg Magnesium from Magnesium citrate once daily

Criteria 

Inclusion Criteria:

Type II Diabetics (HbA1c > 6%)

Exclusion Criteria:

pregnancy, lactation
persons with severe renal impairment (glomerular filtration rate <30 ml / min)
use of insulin, oral antidiabetic drugs, diuretics, antacids or proton pump inhibitors within 4 weeks prior to study start and during the study
intake of vitamin supplements, dietary supplements, mineral products or possibly enriched foods containing Magnesium within 4 weeks before study start and during the study
No Results Posted